Article
Reclassification of intragenic DMD gene duplications by optical genome mapping resolves uncertainty and improves clinical management.
Neuromuscular disorders : NMD - 1 Mar 2026
Seiwert Elizabeth Ulm, Shi Xinrui, Coyan Alyxis, Crawford Sarah, Husami Ammar, Tian Cuixia, Zygmunt Alex, Kushlaf Hani, Liu Jie, Nagaraj Chinmayee B
Abstract excerpt
Pathogenic copy number and sequence variants in the dystrophin (DMD) gene cause X-linked dystrophinopathies. Predicting the clinical consequences of intragenic DMD duplications is challenging because their functional impact depends on the physical location of the duplicated material, which cannot be determined through conventional testing. Optical genome mapping is a method of structural variant analysis that can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
